Latest Commercialisation News

Page 20 of 239
AdAlta says a 10-year, up to US$120 million agreement between manufacturing partner Oribiotech and an undisclosed commercial-stage biopharmaceutical company validates its choice of IRO automation for future cellular immunotherapies. The deal does not create direct revenue for AdAlta, and its lead asset EW-001 will continue with a separate manufacturing process.
Ada Torres
Ada Torres
18 Sept 2026
Central Petroleum has swung to a $4.9 million FY2026 statutory loss after writing down two Amadeus Basin permits, but its gas business generated higher revenue and margins. The company is now betting on Palm Valley drilling, long-term contracts and new east coast acreage to restore growth.
Victor Sage
Victor Sage
17 Sept 2026
Condor Energy has consolidated 100% ownership of its offshore Peru acreage and moved its 1 Tcf Piedra Redonda gas discovery closer to commercialisation. The company enters FY2027 with a larger resource base and stronger project control, but auditors have warned that additional funding is needed to sustain operations.
Victor Sage
Victor Sage
17 Sept 2026
Ionic Rare Earths is pushing toward commercial magnet recycling in Belfast and the United States, but its FY2026 report flags a material uncertainty over its ability to continue as a going concern. The company reported a larger A$14.9 million loss and A$13.9 million in operating cash outflows, despite government support and new strategic partnerships.
Victor Sage
Victor Sage
17 Sept 2026
ABx Group has locked in approximately $4.1 million through a placement and fully underwritten share purchase plan, with strategic partner Good Importing International committing $1 million. The funding will support the Deep Leads rare earths project and construction and commissioning of the ALCORE pilot plant, but comes with substantial new equity and options.
Victor Sage
Victor Sage
17 Sept 2026
Zinc of Ireland has transformed from a small Irish zinc explorer into a metals technology developer, acquiring Meclex, raising A$5.5 million and advancing ARGO and VOLTA. The opportunity is substantial, but both technologies remain uncommercialised and the VOLTA partnership requires formal renewal.
Victor Sage
Victor Sage
16 Sept 2026
ION Video has secured an oversubscribed $4.25 million placement to fund independent trials of its video technology, with directors and management committing a further $1.2 million subject to shareholder approval. The capital will be used to test whether ION’s architecture can deliver measurable technical and financial benefits in real operating environments.
Sophie Babbage
Sophie Babbage
16 Sept 2026
EMVision has completed the first stage of a Melbourne Mobile Stroke Unit study, operating its portable brain scanner in homes, ambulances and a workplace. The small, non-diagnostic feasibility study produced strong usability results while pointing to a larger clinical validation step planned for next-generation units.
Victor Sage
Victor Sage
16 Sept 2026
Lithium Universe has secured selection for a proposed four-year Industry PhD project with Macquarie University and CSIRO to develop microwave-assisted recycling of end-of-life solar panels. The collaboration could strengthen the company’s technology pathway, but its grant, agreement and commercial outcomes remain unconfirmed.
Victor Sage
Victor Sage
15 Sept 2026
Sparc Technologies has reported a 25% reduction in corrosion creep after adding HydroGraph’s Fractal Graphene to its ecosparc protective coating. The result strengthens the commercial case, but a definitive supply agreement remains conditional on longer testing due in November.
Victor Sage
Victor Sage
15 Sept 2026
FBR has opened a fully underwritten A$2.5 million share purchase plan to fund testing and commercialisation of its Mantis and Hadrian robotics platforms. Eligible shareholders can subscribe at the lower of A$0.115 or a discounted five-day VWAP, with one five-year option attached to each share issued.
Victor Sage
Victor Sage
14 Sept 2026
Proteomics International has begun a controlled release of two Promarker diagnostic tests through Healius in Western Australia and the Northern Territory. National commercial sales are targeted for Q2 FY27, but uptake and revenue remain difficult to estimate at this early stage.
Ada Torres
Ada Torres
14 Sept 2026

Browse the archive

Full archive